1. Home
  2. BATL vs NVNO Comparison

BATL vs NVNO Comparison

Compare BATL & NVNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Battalion Oil Corporation

BATL

Battalion Oil Corporation

N/A

Current Price

$1.23

Market Cap

18.8M

Sector

Energy

ML Signal

N/A

Logo enVVeno Medical Corporation

NVNO

enVVeno Medical Corporation

N/A

Current Price

$0.34

Market Cap

16.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BATL
NVNO
Founded
1987
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Medical/Dental Instruments
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.8M
16.7M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
BATL
NVNO
Price
$1.23
$0.34
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
76.2K
551.3K
Earning Date
11-13-2025
10-31-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$183,422,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.00
$0.30
52 Week High
$3.67
$5.62

Technical Indicators

Market Signals
Indicator
BATL
NVNO
Relative Strength Index (RSI) 57.11 35.38
Support Level $1.08 $0.30
Resistance Level $1.25 $0.37
Average True Range (ATR) 0.06 0.04
MACD -0.00 0.01
Stochastic Oscillator 67.74 29.69

Price Performance

Historical Comparison
BATL
NVNO

About BATL Battalion Oil Corporation

Battalion Oil Corp is an independent energy company focused on the acquisition, production, exploration, and development of onshore liquids-rich oil and natural gas assets in the U.S. Its properties and drilling activities are currently focused in the Delaware Basin.

About NVNO enVVeno Medical Corporation

enVVeno Medical Corp is a late clinical-stage medical device company focused on advancing bioprosthetic (tissue-based) solutions to improve the standard of care for treating venous disease. The company's product, VenoValve, is a surgical replacement venous valve that is currently being evaluated in a U.S. pivotal study. The company is also developing a second product called enVVe, which is a non-surgical, transcatheter-based replacement venous valve. Both the products are designed to act as one-way valves to help assist in propelling blood up the veins of the leg, and back to the heart and lungs. The company has determined that it currently operates in a single segment, Medical Device development, located in a single geographic location, the United States.

Share on Social Networks: